GlaxoSmithKline company profile Francis Weyzig Amsterdam‚ October 2004 Summary Business description GlaxoSmithKline (GSK) is one of the world’s largest research-based pharmaceutical corporations that discovers‚ develops‚ manufactures and markets branded human health products. Headquarters: UK‚ with additional operational headquarters in the USA Global presence: about 160 countries Primary markets: USA‚ France‚ Germany‚ UK‚ Italy and Japan Employees: approximately 103‚000 GSK key figures
Premium Pharmaceutical industry
SWOT analysis of the Glaxosmithkline. Glaxosmithkline is‚ after Pfizer Inc‚ the largest pharmaceutical company in the world. It was formed in 2000 as the result of a merger between two large companies GlaxoWellcome and SmithKlineBeecham. The company operates primarily in 117 countries‚ their products are currently manufactured in 37 and are sold in over 140 countries. It is headquartered in Brentford‚ England and employs about 110‚000 people with sales of Ł22.7bn. Their strategies for the future
Premium
April 2013 McClellan GlaxoSmithKline: Ethics and Clinical Thinking GlaxoSmithKline (GSK) is known around the world for many of its home health products and a good number of the prescription drugs that are in our medicine cabinets. GSK is a global healthcare company. They focus on the discovery‚ development‚ manufacturing‚ and marketing of pharmaceutical and consumer health-related products. A brief history of the company‚ according to the Marketline report GlaxoSmithKline: Through Mergers and
Premium
Chapter 1 Introduction To GlaxoSmithKline 1. INTRODUCTION: 1.1 COMPANY LOGO Image 1 GlaxoSmithKline is a leading‚ global‚ research-based healthcare and pharmaceutical company. In India‚ it is the number one pharmaceutical company. GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical‚ biologics‚ vaccines and consumer healthcare company headquartered in Brentford‚ London
Premium Pharmaceutical industry Pharmacology Generic drug
responsibility principles‚ the outcome being a substantial difference to the durability‚ prosperity and liveability of the communities in which they operate (Smith 2008).GlaxoSmithKline is a world leading research based pharmaceutical company‚ with a mission that is challenging and arousing to improve the quality of human life. GlaxoSmithKline has a robust combination of resources and skills delivering strong growth in today’s rapidly changing environment (Pangarkar 2006). The company also has leadership
Premium Social responsibility Corporate social responsibility
Corporate Social Responsibility: What Went Wrong at GlaxoSmithKline? When London-based GlaxoSmithKline (GSK) paid a $750 million dollar settlement as part of a plea agreement that required it’s Cidra‚ Puerto Rico subsidiary SB Pharmco to plead guilty for knowingly selling contaminated medicine‚ it laid to rest any doubts that its business practices were in direct conflict with its commitment to both quality and to creating a strong ethical culture. There are‚ nevertheless‚ important issues
Premium Management Pharmacology Food and Drug Administration
Internship Report On Standard Costing Procedure & Cost Variance Analysis: A Study on GlaxoSmithKline Bd. Ltd. Submitted To Mr. Syed Manzur Quader Lecturer Independent University‚ Bangladesh Chittagong Submitted By TASBEER AKTAR ABEER ID#0311022 Independent University‚ Bangladesh Date of Submission: 10th September‚ 2007 Letter of Transmittal Monday‚ September 10‚ 2007 To Mr. Syed Manzur Quader Lecturer‚ Independent University‚ Bangladesh Chittagong Sub: Submission of Internship Report.
Premium Cost accounting Costs Variable cost
GlaxoSmithKline 1. Who are the stakeholders in this case? Which are primary‚ and which are secondary? What influence do they have? Stakeholders for GlaxoSmithKline include the following: Employees; stockholders; creditors; suppliers; customers (both prescribing physicians and end users); retailers (domestically and internationally); activist groups (such as the Minnesota Senior Federation‚ the National Association of the Terminally Ill‚ the Coalition for Access to Affordable Prescription
Premium Pharmacology Pharmaceutical industry Food and Drug Administration
Glaxo Smith Kline Panoxyl Date Submitted November‚ 9‚ 2012 Prepared By Colin Williams BUS 360 SECTION 001 Table of Contents company offering product/SERVICE 1 Company Description 1 Company Location(s) 1 Other Products Offered 1 Market Areas Sells To 1 product/SERVICE being marketed 2 Description of Product 2 Features and Capabilities 2 Product Life Cycle 2‚ 3 Market
Premium Marketing
thinking: future direction of the competition; needs of customers; gaining and maintaining competitive advantage; Ansoff’s growth-vector matrix; portfolio analysis Introduction Based on a report conducted by a pharmaceutical magazine‚ Glaxosmithkline plc (Also known as GSK) is the fifth largest pharmaceutical company around the world (Contract Pharma‚ 2013). And it is also tided at No.112 on the 2013 ’s Global 2000 list‚ the list that manifests the 2000 most enormous companies in the world
Premium Strategic management Pharmaceutical industry